For some patients, compassionate use programmes (CUPs) are the only way to access promising medicinal products that are not yet authorized and for which clinical trials are either not available or in which these patients cannot participate.
Published in 2010 in Pharma Medecine Journal
All our resources
blog
2024 is here and will be a crucial year for your clinical trials in the European Union (EU) and European…
blog
The adoption of Electronic Patient-Reported Outcomes (ePRO) in clinical research marks a significant evolution in the way patient-centered data is…
webinar
Embracing an Early Access Program (EAP) presents a strategic avenue for creating valuable opportunities for patients and companies. This webinar…
whitepaper
There are multiple definitions associated with a registry and any future sponsors can feel anxious when it is time to…
